nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8+ T cells and antibody when expressed from modified vaccinia Ankara
|
Quinan, Bárbara R. |
|
2014 |
32 |
25 |
p. 2972-2979 8 p. |
artikel |
2 |
A qualitative analysis of the impact of healthcare personnel influenza vaccination requirements in California
|
Khodyakov, Dmitry |
|
2014 |
32 |
25 |
p. 3082-3087 6 p. |
artikel |
3 |
A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)
|
Phan, Shannon I. |
|
2014 |
32 |
25 |
p. 3050-3057 8 p. |
artikel |
4 |
Attenuated Mycoplasma bovis strains provide protection against virulent infection in calves
|
Zhang, Rui |
|
2014 |
32 |
25 |
p. 3107-3114 8 p. |
artikel |
5 |
Comment on “Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3−CD70−CD27+IgM+CD43+CD5+/−”
|
Verbinnen, Bert |
|
2014 |
32 |
25 |
p. 2940-2941 2 p. |
artikel |
6 |
Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza
|
Tabynov, K. |
|
2014 |
32 |
25 |
p. 2965-2971 7 p. |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
25 |
p. CO2- 1 p. |
artikel |
8 |
Effectiveness of the monovalent rotavirus vaccine in Colombia: A case-control study
|
Cotes-Cantillo, Karol |
|
2014 |
32 |
25 |
p. 3035-3040 6 p. |
artikel |
9 |
Effects of recruitment strategies and demographic factors on inclusion in a large scale vaccination trial in adults 65 years and older
|
Smorenburg, Andre J. |
|
2014 |
32 |
25 |
p. 2989-2994 6 p. |
artikel |
10 |
Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena
|
Trus, Ivan |
|
2014 |
32 |
25 |
p. 2995-3003 9 p. |
artikel |
11 |
Estimating vaccination coverage against tick-borne encephalitis
|
Grgič-Vitek, Marta |
|
2014 |
32 |
25 |
p. 2944- 1 p. |
artikel |
12 |
Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus
|
Morozova, O.V. |
|
2014 |
32 |
25 |
p. 3101-3106 6 p. |
artikel |
13 |
Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets
|
Onishi, Motoyasu |
|
2014 |
32 |
25 |
p. 3004-3009 6 p. |
artikel |
14 |
Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older
|
Nelson, Noele P. |
|
2014 |
32 |
25 |
p. 2939- 1 p. |
artikel |
15 |
Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein
|
Uppalapati, Siva R. |
|
2014 |
32 |
25 |
p. 3075-3081 7 p. |
artikel |
16 |
How advances in immunology provide insight into improving vaccine efficacy
|
Slifka, Mark K. |
|
2014 |
32 |
25 |
p. 2948-2957 10 p. |
artikel |
17 |
Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults
|
Paul, Anu |
|
2014 |
32 |
25 |
p. 3094-3100 7 p. |
artikel |
18 |
Is it necessary to adjust for calendar time in a test negative design?
|
Jacoby, Peter |
|
2014 |
32 |
25 |
p. 2942- 1 p. |
artikel |
19 |
Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4
|
Gromowski, Gregory D. |
|
2014 |
32 |
25 |
p. 3010-3018 9 p. |
artikel |
20 |
Optimizing benefits of influenza virus vaccination during pregnancy: Potential behavioral risk factors and interventions
|
Christian, Lisa M. |
|
2014 |
32 |
25 |
p. 2958-2964 7 p. |
artikel |
21 |
Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice
|
Takei, Saki |
|
2014 |
32 |
25 |
p. 3066-3074 9 p. |
artikel |
22 |
Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice
|
Liu, Qiliang |
|
2014 |
32 |
25 |
p. 3041-3049 9 p. |
artikel |
23 |
Reply to: Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact
|
Wassil, James |
|
2014 |
32 |
25 |
p. 2943- 1 p. |
artikel |
24 |
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial
|
Prymula, Roman |
|
2014 |
32 |
25 |
p. 3025-3034 10 p. |
artikel |
25 |
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine
|
Daley, Matthew F. |
|
2014 |
32 |
25 |
p. 3019-3024 6 p. |
artikel |
26 |
Sources of information for assessing human papillomavirus vaccination history among young women
|
Niccolai, Linda M. |
|
2014 |
32 |
25 |
p. 2945-2947 3 p. |
artikel |
27 |
Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice
|
Li, Zhong-Yuan |
|
2014 |
32 |
25 |
p. 3058-3065 8 p. |
artikel |
28 |
System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic
|
Davila-Payan, Carlo |
|
2014 |
32 |
25 |
p. 3088-3093 6 p. |
artikel |
29 |
The adjuvant component α-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy
|
Masoudi, Sanita |
|
2014 |
32 |
25 |
p. 2980-2988 9 p. |
artikel |